Browse Category

Stock Market 9 July 2026

Virax Biolabs (NASDAQ:VRAX) Soars 183% After Fosun Deal

Virax Biolabs (NASDAQ:VRAX) Soars 183% After Fosun Deal

Virax Biolabs Group shares jumped more than 100% during Thursday’s U.S. session after the diagnostics company said its UK subsidiary reached an exclusive multi-country supply deal with Fosun Diagnostics for its ImmuneSelect research-use immune-profiling line. The Nasdaq stock was trading at $9.00 as of 11:52 a.m. EDT, up $5.82 on the day, with about 57.8 million shares changing hands.
Tesla–SpaceX merger rumors get $500 target, Wall Street takes notice

Tesla–SpaceX merger rumors get $500 target, Wall Street takes notice

Tesla shares climbed Thursday morning after RBC Capital lifted its price target to $500. The move puts a number on a merger scenario with SpaceX, which is still just speculation at this point. RBC's Tom Narayan said, “Raise PT to $500 on Potential SpaceX Combination.” Narayan said the new target bakes in a 25% to 30% premium for a possible SpaceX deal, even though those reports are unconfirmed.
AI Stocks Face Their Biggest Test Yet as Micron’s $250 Billion Bet Raises the Bar

AI Stocks Face Their Biggest Test Yet as Micron’s $250 Billion Bet Raises the Bar

Micron Technology’s plan to invest more than $250 billion in the United States through 2035 gave Wall Street a fresh marker for the artificial intelligence trade on Thursday: the spending boom is real, and it now has to show returns. Micron said the plan was driven by demand for memory chips in the AI era, while its shares rose about 8% in early trading.
1 77 78 79 80 81 1,710
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.